In NSCLC patients undergoing chemotherapy, Ganoderma lucidum spores (oral administration at 1.5 g/day) increased CD4+ T cell levels and the CD4+/CD8+ ratio, suggesting improved cellular immunity [107]. This evidence concerns the gene CD4 and non-small cell lung carcinoma.